CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AE0. A total of 8 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $164,000 | -11.4% | 250,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $185,000 | -93.9% | 250,000 | -93.8% | 0.00% | -92.9% |
Q4 2021 | $3,040,000 | -16.2% | 4,000,000 | 0.0% | 0.03% | -9.7% |
Q3 2021 | $3,629,000 | +129.8% | 4,000,000 | +166.7% | 0.03% | +158.3% |
Q2 2021 | $1,579,000 | -8.2% | 1,500,000 | 0.0% | 0.01% | -20.0% |
Q1 2021 | $1,720,000 | +32.8% | 1,500,000 | 0.0% | 0.02% | +50.0% |
Q4 2020 | $1,295,000 | -10.2% | 1,500,000 | 0.0% | 0.01% | -23.1% |
Q3 2020 | $1,442,000 | – | 1,500,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 64,842,000 | $63,520,000 | 3.42% |
QVT Financial LP | 15,000,000 | $14,638,000 | 1.79% |
ARISTEIA CAPITAL, L.L.C. | 22,150,000 | $21,214,000 | 0.87% |
WHITEBOX ADVISORS LLC | 9,300,000 | $8,861,000 | 0.37% |
LMR Partners LLP | 13,099,000 | $12,793,000 | 0.26% |
CAPSTONE INVESTMENT ADVISORS, LLC | 6,100,000 | $5,842,000 | 0.03% |
WOLVERINE ASSET MANAGEMENT LLC | 1,500,000 | $1,442,000 | 0.01% |
WELLS FARGO & COMPANY/MN | 2,025,000 | $1,982,000 | 0.00% |
DEUTSCHE BANK AG\ | 1,968,000 | $1,875,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |